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Purpose
Resistance to cancer chemotherapy is a major problem.
Herb-drug combinations can offer a new potential to
overcome such resistance. To quantitatively assess che-
mosensitizing effects of herb-drug combinations (HDC),
a new approach that takes into account both the chemo-
sensitizing effect (CE) and “safety” considerations of the
HDC is proposed and used in describing the cytotoxic
activity of Tripterygium wilfordii-docetaxel (TW-Dtx)
combination on prostate cancer cell lines.
Methods
The effect of two extracts of TW with Dtx on Dtx resis-
tant PC3 and DU145 cell lines were compared. Cell via-
bility (cytotoxicity) was determined using
sulforhodamine B assay after incubation of the cell line.
The IC50 of herb (H), drug (D) alone and in combina-
tion (IC50H, IC50D, and IC50CD respectively) in resistant
cells were obtained. CE and chemosensitizing utility
index (CUI) were calculated as: CE = IC50D IC50CD;
CUI=CE (IC50H/ConH) whereas ConH is the H concen-
tration in the combination.
Results
The values for CE (fold change), CUI (fold change), and
IC50CD (nM) from TW extract A-Dtx treatment in
resistant PC3 cells were 3.8 , 5.8, and 5.8, respectively
versus 17.1, 22.0, and 1.5, respectively from TW extract
B-Dtx treatment when low ConH relative to IC50H was
used. The corresponding values from extract A versus
B-Dtx treatment in resistant DU145 cells were >1.3,
>4.5 and 75.3 versus >27.6, >55.2 and 3.63, respectively.
However, CE values can dramatically increase with
higher ConH.
Conclusion
Based on the above CE, CUI or ICCD values, TW
extract B-Dtx appeared to be consistently superior to
extract A-Dtx combination. However, assessment based
on CE value alone may be misleading since it can
change dramatically with ConH used. CUI together with
IC50CD are preferred and may prove to be a useful
practical tool for assessing chemosensitizing effect of
other HDCs.
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